Free Trial

Needham & Company LLC's Rating of Gilead Sciences on 10/30/2026

On October 30, 2026, Needham & Company LLC updated its outlook on Gilead Sciences (NASDAQ:GILD) with the action "Set Price Target", setting a price target of $175.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Needham & Company LLC

DateCompanyAction
10/30/2026
Reddit Inc. stock logo
RDDT
Reddit
Lower Price Target
10/30/2026
Roblox Corporation stock logo
RBLX
Roblox
Reiterated Rating
10/30/2026
Monolithic Power Systems, Inc. stock logo
MPWR
Monolithic Power Systems
Reiterated Rating
10/30/2026
ResMed Inc. stock logo
RMD
ResMed
Reiterated Rating
10/30/2026
Fiverr International stock logo
FVRR
Fiverr International
Reiterated Rating
10/30/2026
DoorDash, Inc. stock logo
DASH
DoorDash
Lower Price Target
More Ratings From Needham & Company LLC